Zacks Research Estimates Teleflex’s Q4 Earnings (NYSE:TFX)

Teleflex Incorporated (NYSE:TFX) – Equities researchers at Zacks Research upped their Q4 2025 earnings per share (EPS) estimates for shares of Teleflex in a report released on Tuesday, April 29th. Zacks Research analyst R. Department now expects that the medical technology company will earn $3.90 per share for the quarter, up from their prior estimate of $3.89. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q4 2026 earnings at $3.74 EPS.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.88 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. During the same quarter in the prior year, the firm posted $3.21 EPS. The business’s revenue was down 5.0% on a year-over-year basis.

Other equities research analysts have also recently issued research reports about the company. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Truist Financial lowered their price objective on Teleflex from $149.00 to $140.00 and set a “hold” rating on the stock in a research report on Friday, April 11th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Finally, Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Teleflex has a consensus rating of “Hold” and an average price target of $169.63.

Teleflex Stock Performance

Shares of TFX stock opened at $126.59 on Thursday. Teleflex has a 52 week low of $124.66 and a 52 week high of $249.91. The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 1.73 and a beta of 1.19. The company has a 50-day simple moving average of $136.84 and a 200 day simple moving average of $171.53. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Hedge Funds Weigh In On Teleflex

A number of institutional investors have recently modified their holdings of the business. CANADA LIFE ASSURANCE Co raised its stake in Teleflex by 0.4% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company’s stock worth $3,614,000 after acquiring an additional 74 shares in the last quarter. Hengehold Capital Management LLC increased its position in Teleflex by 7.3% during the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after purchasing an additional 88 shares in the last quarter. Exchange Traded Concepts LLC lifted its stake in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock valued at $27,000 after buying an additional 100 shares in the last quarter. Finally, True Wealth Design LLC grew its stake in shares of Teleflex by 62.3% during the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock worth $48,000 after buying an additional 104 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date was Friday, March 7th. Teleflex’s dividend payout ratio is presently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.